実績について

MENU
トップページ
キービジュアル

PERFOMANCE

当科実績のご紹介

2017年 2018年 2019年
手術総数 446 454 414

実績の内訳

脳腫瘍手術
2017年 2018年 2019年
(1)広範囲頭蓋底腫瘍切除・再建術 43 35 30
(2)経蝶形骨洞摘出術 41 52 46
脳腫瘍手術総数200223193
脳血管障害治療総数(血管内+開頭)
2017年 2018年 2019年
(1)脳動脈瘤直達術(クリッピング等) 35 21 18
(2)動静脈奇形・瘻 0 3 2
(3)頚動脈内膜剥離術 3 3 2
(4)バイパス手術 3 8 6
(5)高血圧性脳内血腫除去 4 4 5
脳血管障害直達手術総数453933
(1)脳動脈瘤塞栓術 23 15 23
(2)動静脈奇形・瘻 19 16 19
(3)閉塞性脳血管障害(ステントなど) 32 18 19
脳血管内手術総数745773
脳血管障害治療総数(血管内+開頭)11796106
機能的手術
2017年 2018年 2019年
(1)不随意運動、頑痛症刺激術 5 3 0
(2)脳神経減圧術 6 3 5
機能的手術総数1165
水頭症手術
2017年 2018年 2019年
(1)脳室シャント術 25 16 26
(2)内視鏡手術 7 3 12
水頭症手術総数342539
小児脳神経外科(15歳以下)手術
2017年 2018年 2019年
(1)小児脳腫瘍 7 5 6
(2)頭蓋骨早期癒合症 17 19 20
小児脳神経外科(15歳以下)手術総数403442
頭部外傷手術
2017年 2018年 2019年
(1)開頭術 5 7 7
(2)慢性硬膜下血腫穿頭術 25 25 27
頭部外傷手術総数303234

2021年

  • Risk factor for cerebrospinal fluid leak after endoscopic endonasal skull base surgery: a single-center experience. Ozawa H, Sekimizu M, Saito S, Nakamura S, Mikoshiba T, Watanabe Y, Ikari Y, Toda M, Ogawa K. Acta Otolaryngol. 2021 Mar 18:1-5.
  • Endoscopic Endonasal Transinfraturbinate Approach With Nasoseptal Window for Removal of the Pterygopalatine Fossa Tumor. Yamada H, Toda M, Abiko T, Ozawa H, Ogawa K, Yoshida K. J Craniofac Surg. 2021 Mar-Apr 01;32(2):716-718.
  • Angio-anatomical study of the pterygovaginal artery based on cone-beam computed tomography.Yoshida K, Akiyama T, Raz E, Kamamoto D, Ozawa H, Toda M. Neuroradiology. 2021 Feb 8.
  • Comparisons of Characteristics and Outcomes after Mechanical Thrombectomy for Vertebrobasilar Occlusion with Cardioembolism or Atherosclerotic Brain Infarction: Data from the Tokyo-Tama-Registry of Acute Endovascular Thrombectomy (TREAT). Katsumata M, Ota T, Tsuruta W, Akiyama T, Sakai Y, Shigeta K, Kaneko J, Nogawa S, Ichijo M, Shiokawa Y, Hirano T. World Neurosurg. 2021 Jan 26:S1878-8750(21)00102-9.
  • In-Hospital Complications After Surgery in Elderly Patients with Asymptomatic or Minor Symptom Meningioma: A Nationwide Registry Study. Ikawa F, Isobe N, Michihata N, Oya S, Ohata K, Saito K, Yoshida K, Fushimi K, Yasunaga H, Tominaga T, Kurisu K. World Neurosurg. 2021 Jan 11:S1878-8750(21)00020-6.
  • Cystic Dumbbell-Shaped C1 Schwannoma with Intracranial Extension and Hydrocephalus. Matsui Y, Fukumura M, Toda M. World Neurosurg. 2021 Jan 11;148:24-28.
  • Effect of gravity on brain structure as indicated on upright computed tomography. Yokoyama Y, Yamada Y, Kosugi K, Yamada M, Narita K, Nakahara T, Fujiwara H, Toda M, Jinzaki M. Sci Rep. 2021 Jan 11;11(1):392.
  • Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Patients With Meningiomas. Kuranari Y, Tamura R, Tsuda N, Kosugi K, Morimoto Y, Yoshida K, Toda M. Front Oncol. 2020 Nov 24;10:592470.
  • Quiescent and Activated Fibroblasts in Lateral Ventricular Meningioma With a Dura-like Membrane. Sato M, Tamura R, Morimoto Y, Oishi Y, Yoshida K, Toda M. World Neurosurg. 2021 Mar;147:e215-e224.
  • Activation of ventral CA1 hippocampal neurons projecting to the lateral septum during feeding. Kosugi K, Yoshida K, Suzuki T, Kobayashi K, Yoshida K, Mimura M, Tanaka KF. Hippocampus. 2021 Mar;31(3):294-304.
  • A case of moyamoya disease symptomatized early after nivolumab initiation - Possible association between immune checkpoint inhibitors and moyamoya disease. Takahashi S, Matsui Y, Kubo H, Toda M. Clin Neurol Neurosurg. 2021 Jan;200:106355.
  • Assessment of long-term quality of life in patients with syndromic craniosynostosis. Sakamoto Y, Takenouchi T, Miwa T, Kishi K. J Plast Reconstr Aesthet Surg. 2021 Feb;74(2):336-340.
  • Orthostatic Enlargement of a Supracerebellar Arachnoid Cyst With Cerebellar Descent Visualized by Upright Computed Tomography. Yoshida K, Toda M, Yamada Y, Yamada M, Yokoyama Y, Fujiwara H, Kosugi K, Sasaki H, Jinzaki M. World Neurosurg. 2021 Jan;145:256-259.

2020年

  • Endoscopic Endonasal Management of Pterygopalatine Fossa Tumors. Ozawa H, Sekimizu M, Saito S, Nakamura S, Mikoshiba T, Toda M, Ogawa K. J Craniofac Surg. 2020 Nov 25.
  • TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations. Arita H, Matsushita Y, Machida R, Yamasaki K, Hata N, Ohno M, Yamaguchi S, Sasayama T, Tanaka S, Higuchi F, Iuchi T, Saito K, Kanamori M, Matsuda KI, Miyake Y, Tamura K, Tamai S, Nakamura T, Uda T, Okita Y, Fukai J, Sakamoto D, Hattori Y, Pareira ES, Hatae R, Ishi Y, Miyakita Y, Tanaka K, Takayanagi S, Otani R, Sakaida T, Kobayashi K, Saito R, Kurozumi K, Shofuda T, Nonaka M, Suzuki H, Shibuya M, Komori T, Sasaki H, Mizoguchi M, Kishima H, Nakada M, Sonoda Y, Tominaga T, Nagane M, Nishikawa R, Kanemura Y, Kuchiba A, Narita Y, Ichimura K. Acta Neuropathol Commun. 2020 Nov 23;8(1):201.
  • A questionnaire-based survey to evaluate and improve the current HHT medical and social condition in Japan. Arai N, Akiyama T. Surg Neurol Int. 2020 Oct 2;11:323.
  • [Endoscopic Endonasal Skull Base Surgery Using the 'Four Hands-Two Nostrils' Technique by a Surgical Team Composed of an ENT Surgeon and a Neurosurgeon]. Toda M, Ueda R, Ozawa H. No Shinkei Geka. 2020 Oct;48(10):885-893.
  • Targeted embolisation for coexisting conus medullaris arteriovenous malformation and cauda equina arteriovenous fistulas with a varix on a shared drainer†. Yoshida K, Niimi Y, Kamamoto D, Fukumura M, Imai R, Nagoshi N, Akiyama T. Br J Neurosurg. 2020 Oct 9:1-6.
  • Posture-induced changes in the vessels of the head and neck: evaluation using conventional supine CT and upright CT. Kosugi K, Yamada Y, Yamada M, Yokoyama Y, Fujiwara H, Yoshida K, Yoshida K, Toda M, Jinzaki M. Sci Rep. 2020 Oct 6;10(1):16623.
  • Pros and Cons of the Exoscope for Otologic Surgery. Kanzaki S, Takahashi S, Toda M, Yoshida K, Ogawa K. Surg Innov. 2020 Sep 29:1553350620964151.
  • Historic Overview of Genetic Engineering Technologies for Human Gene Therapy. Tamura R, Toda M. Neurol Med Chir (Tokyo). 2020 Oct 15;60(10):483-491.
  • Endoscopic Endonasal Transinfraturbinate Approach With Nasoseptal Window for Removal of the Pterygopalatine Fossa Tumor. Yamada H, Toda M, Abiko T, Ozawa H, Ogawa K, Yoshida K. J Craniofac Surg. 2020 Sep 3.
  • A Pilot Study of the Adverse Events Caused by the Combined Use of Bevacizumab and Vascular Endothelial Growth Factor Receptor-Targeted Vaccination for Patients with a Malignant Glioma. Tamura R, Morimoto Y, Sato M, Hikichi T, Yoshida K, Toda M. Vaccines (Basel). 2020 Sep 2;8(3):498.
  • Delayed reopening of a superficial temporal artery to middle cerebral artery bypass graft occluded by a white thrombus during surgery. Takahashi S, Yoshida K. Surg Neurol Int. 2020 Aug 1;11:220.
  • Antifungal Agent Luliconazole Inhibits the Growth of Mouse Glioma-initiating Cells in Brain Explants. Nagashima H, Koike N, Yoshida K, Saya H, Sampetrean O. Keio J Med. 2020 Dec 25;69(4):97-104.
  • Exchange Cranioplasty Using Bioabsorbable Hydroxyapatite and Collagen Complex After Removal of an Extensive Frontal Bone Tumor in an Infant. Kono M, Miwa T, Sakamoto Y, Kishi K, Yoshida K. World Neurosurg. 2020 Oct;142:375-378.
  • Relationship between ischaemic symptoms during the early postoperative period in patients with moyamoya disease and changes in the cerebellar asymmetry index. Takahashi S, Horiguchi T. Clin Neurol Neurosurg. 2020 Oct;197:106090.
  • Sinking skin flap syndrome visualized by upright computed tomography. Yoshida K, Toda M, Yamada Y, Yamada M, Yokoyama Y, Fujiwara H, Kosugi K, Fukumura M, Koike K, Takahashi S, Yoshida K, Jinzaki M. Acta Neurochir (Wien). 2020 Aug;162(8):1825-1828.
  • Central nervous system ganglioneuroblastoma harboring MYO5A-NTRK3 fusion. Ito J, Nakano Y, Shima H, Miwa T, Kogure Y, Isshiki K, Yamazaki F, Oishi Y, Morimoto Y, Kataoka K, Okita H, Hirato J, Ichimura K, Shimada H. Brain Tumor Pathol. 2020 Jul;37(3):105-110.
  • Novel histopathological classification of meningiomas based on dural invasion. Murase M, Tamura R, Kuranari Y, Sato M, Ohara K, Morimoto Y, Yoshida K, Toda M. J Clin Pathol. 2020 Apr;74(4):238-243.
  • Cerebrospinal fluid leakage due to nasoseptal flap partial necrosis: A pitfall for skull base reconstruction of endoscopic endonasal surgery. Yamada H, Toda M, Fukumura M, Imai R, Ozawa H, Ogawa K, Yoshida K. Surg Neurol Int. 2020 May 23;11:121.
  • Genetic analysis in patients with newly diagnosed glioblastomas treated with interferon-beta plus temozolomide in comparison with temozolomide alone. Natsume A, Aoki K, Ohka F, Maeda S, Hirano M, Adilijiang A, Motomura K, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S, Okuno Y, Wakabayashi T; and Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). J Neurooncol. 2020 May;148(1):17-27.
  • Alterations of the tumor microenvironment in glioblastoma following radiation and temozolomide with or without bevacizumab. Tamura R, Tanaka T, Morimoto Y, Kuranari Y, Yamamoto Y, Takei J, Murayama Y, Yoshida K, Sasaki H. Ann Transl Med. 2020 Mar;8(6):297.
  • A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2. Tamura R, Fujioka M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Sato M, Ueda R, Fujiwara H, Hikichi T, Noji S, Oishi N, Ogawa K, Kawakami Y, Ohira T, Yoshida K, Toda M. Nat Commun. 2020 Apr 21;11(1):2028.
  • Novel method to evaluate the risk of tumor adhesions and post-operative hemorrhage of meningiomas using 320 row CT-DSA: A clinical research study. Arai N, Mizutani K, Horiguchi T, Akiyama T, Takahashi S, Yanagisawa K, Koike K, Yoshida K. Acta Neurochir (Wien). 2020 Sep;162(9):2145-2153.
  • Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series. Tamura R, Morimoto Y, Kosugi K, Sato M, Oishi Y, Ueda R, Kikuchi R, Nagashima H, Hikichi T, Noji S, Kawakami Y, Sasaki H, Yoshida K, Toda M. BMC Cancer. 2020 Apr 14;20(1):301.
  • Delayed-Onset Familial Sagittal Suture Synostosis. Kitabata R, Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2020 Jul-Aug;31(5):e475-e477.
  • Clipping versus coiling in unruptured anterior cerebral circulation aneurysms. Mohammad F, Horiguchi T, Mizutani K, Yoshida K. Surg Neurol Int. 2020 Mar 21;11:50.
  • Loss of consciousness at ictus and/or poor World Federation of Neurosurgical Societies grade on admission reflects the impact of EBI and predicts poor outcome in patients with SAH. Takahashi S, Akiyama T, Horiguchi T, Miwa T, Takemura R, Yoshida K. Surg Neurol Int. 2020 Mar 6;11:40.
  • The Japan Neurosurgical Database: Overview and Results of the First-year Survey. Iihara K, Tominaga T, Saito N, Suzuki M, Date I, Fujii Y, Hongo K, Houkin K, Kato A, Kato Y, Kawamata T, Kim P, Kinouchi H, Kohmura E, Kurisu K, Maruyama K, Mikuni N, Miyamoto S, Morita A, Nakase H, Narita Y, Nishikawa R, Nozaki K, Ogasawara K, Ohata K, Sakai N, Sakamoto H, Shiokawa Y, Sonoda Y, Takahashi JC, Ueki K, Wakabayashi T, Yamamoto T, Yoshida K, Kayama T, Arai H; Japan Neurosurgical Society. Neurol Med Chir (Tokyo). 2020 Apr 15;60(4):165-190.
  • Gorham-Stout disease with parietal bone osteolysis: a case series and review of literature. Takaya K, Sakamoto Y, Miwa T, Yoshida K, Kishi K. Br J Neurosurg. 2020 Feb;35(1):27-31.
  • Efficacy of a topical gelatin-thrombin hemostatic matrix, FLOSEAL®, in intracranial tumor resection. Kamamoto D, Kanazawa T, Ishihara E, Yanagisawa K, Tomita H, Ueda R, Jinzaki M, Yoshida K, Toda M. Surg Neurol Int. 2020 Feb 7;11:16.
  • Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors. Tamura R, Sato M, Morimoto Y, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Murase M, Yoshida K, Toda M. Exp Mol Pathol. 2020 Jun;114:104408.
  • Gene Therapy Using Neural Stem/Progenitor Cells Derived from Human Induced Pluripotent Stem Cells: Visualization of Migration and Bystander Killing Effect. Tamura R, Miyoshi H, Morimoto Y, Oishi Y, Sampetrean O, Iwasawa C, Mine Y, Saya H, Yoshida K, Okano H, Toda M. Hum Gene Ther. 2020 Mar;31(5-6):352-366.
  • Immunohistochemistry for O6-methylguanin-DNA methyltransferase in glioblastomas defined by WHO2016: Correlation with promoter methylation status and patients' progression-free survival with the cut-off value determined by ROC analysis. Pareira ES, Kitano Y, Ohara K, Kanazawa T, Nakagawa Y, Yoshida K, Sasaki H. J Clin Neurosci. 2020 Mar;73:231-236.
  • Surgical outcomes of anterior cerebellopontine angle meningiomas using the anterior transpetrosal approach compared with the lateral suboccipital approach. Hassaan SA, Tamura R, Morimoto Y, Kosugi K, Mahmoud M, Abokerasha A, Moussa A, Toda M, Yoshida K. Acta Neurochir (Wien). 2020 Jun;162(6):1243-1248.
  • Temozolomide radiochemotherapy for high-grade glioma patients with hemodialysis: a case series of 7 patients. Muto J, Matsutani T, Matsuda R, Kinoshita M, Oikawa M, Pallud J, Sasaki H. Neurooncol Pract. 2020 Jan;7(1):111-117.
  • Analysis of the superficial middle cerebral vein in sphenoid ridge meningioma using contrast-enhanced dynamic computed tomography angiography. Murase M, Mizutani K, Kawata K, Fujiwara H, Jinzaki M, Toda M, Yoshida K. Clin Neurol Neurosurg. 2020 Apr;191:105683.
  • Silent MRA: arterial spin labeling magnetic resonant angiography with ultra-short time echo assessing cerebral arteriovenous malformation. Arai N, Akiyama T, Fujiwara K, Koike K, Takahashi S, Horiguchi T, Jinzaki M, Yoshida K. Neuroradiology. 2020 Apr;62(4):455-461.
  • Difference in the hypoxic immunosuppressive microenvironment of patients with neurofibromatosis type 2 schwannomas and sporadic schwannomas. Tamura R, Morimoto Y, Sato M, Kuranari Y, Oishi Y, Kosugi K, Yoshida K, Toda M. J Neurooncol. 2020 Jan;146(2):265-273.
  • Prediction of postoperative recurrence of chronic subdural hematoma using quantitative volumetric analysis in conjunction with computed tomography texture analysis. Kanazawa T, Takahashi S, Minami Y, Jinzaki M, Toda M, Yoshida K. J Clin Neurosci. 2020 Feb;72:270-276.
  • The Correlation of Fluorescence of Protoporphyrinogen IX and Status of Isocitrate Dehydrogenase in Gliomas. Ohba S, Murayama K, Kuwahara K, Pareira ES, Nakae S, Nishiyama Y, Adachi K, Yamada S, Sasaki H, Yamamoto N, Abe M, Mukherjee J, Hasegawa M, Pieper RO, Hirose Y. Neurosurgery. 2020 Aug 1;87(2):408-417.
  • A Comparative Study Between Traditional Microscopic Surgeries and Endoscopic Endonasal Surgery for Skull Base Chordomas. Yumiko Oishi, Tamura R, Takahashi S, Morimoto Y, Sato M, Horikoshi T, Hassaan S, Yoshida K, Toda M. World Neurosurg. 2020 Feb;134:e1099-e1107.
  • Recent progress in the research of suicide gene therapy for malignant glioma. Tamura R, Miyoshi H, Yoshida K, Okano H, Toda M. Neurosurg Rev. 2021 Feb;44(1):29-49.
  • Tumor immune microenvironment is associated with the growth of intracranial germinomas. Nishimoto M, Ohara K, Kamamoto D, Tamura R, Miwa T, Yoshida K, Sasaki H. J Neurooncol. 2020 Jan;146(1):139-146.
  • Complications of craniofacial surgery using the ultrasonic-assisted pinned resorbable system: A prospective report with a minimum follow-up of 30 months. Nakajima Y, Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Plast Reconstr Aesthet Surg. 2020 Mar;73(3):586-589.
  • Early prediction of clinical outcomes in patients with aneurysmal subarachnoid hemorrhage using computed tomography texture analysis. Kanazawa T, Takahashi S, Minami Y, Jinzaki M, Toda M, Yoshida K. J Clin Neurosci. 2020 Jan;71:144-149.
  • Hemodynamic stress distribution identified by SPECT reflects ischemic symptoms of Moyamoya disease patients. Arai N, Horiguchi T, Takahashi S, Nakahara T, Akiyama T, Jinzaki M, Yoshida K. Neurosurg Rev. 2020 Oct;43(5):1323-1329.
  • Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion. Kanazawa T, Minami Y, Takahashi H, Fujiwara H, Toda M, Jinzaki M, Yoshida K, Sasaki H. Neurosurg Rev. 2020 Aug;43(4):1211-1219.
  • Current understanding of lymphatic vessels in the central nervous system. Tamura R, Yoshida K, Toda M. Neurosurg Rev. 2020 Aug;43(4):1055-1064.

2019年

  • Long-Term Clinical Outcome of First Recurrence Skull Base Meningiomas. Kuranari Y, Tamura R, Tsuda N, Kosugi K, Morimoto Y, Yoshida K, Toda M. J Clin Med. 2019 Dec 31;9(1):106.
  • Relationship between pneumatization of lateral recess in the sphenoid sinus and removal of cavernous sinus invasion in pituitary adenomas by endoscopic endonasal surgery. Kosugi K, Tamura R, Mase T, Tamura H, Jinzaki M, Yoshida K, Toda M. Surg Neurol Int. 2019 Nov 15;10:222.
  • The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications. Tamura R, Tanaka T, Akasaki Y, Murayama Y, Yoshida K, Sasaki H. Med Oncol. 2019 Nov 11;37(1):2.
  • [Diagnosis and Treatment of Intracranial Dural Arteriovenous Fistulas in View of Pathophysiology]. Akiyama T. No Shinkei Geka. 2019 Sep;47(9):927-941.
  • Identification of KLRC2 as a candidate marker for brain tumor-initiating cells. Ishihara E, Takahashi S, Fukaya R, Ohta S, Yoshida K, Toda M. Neurol Res. 2019 Nov;41(11):1043-1049.
  • Analysis of Temporobasal Vein with Short Subdural Segment for Anterior Transpetrosal Approach. Tamura R, Toda M, Morimoto Y, Sato M, Akiyama T, Yoshida K. World Neurosurg. 2019 Dec;132:e554-e562.
  • Reossification of the skull base after fronto-orbital advancement for craniosynostosis. Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Plast Reconstr Aesthet Surg. 2019 Oct;72(10):1700-1738.
  • A Novel Flow Dynamics Study of the Intracranial Veins Using Whole Brain Four-Dimensional Computed Tomography Angiography. Mizutani K, Arai N, Toda M, Akiyama T, Fujiwara H, Jinzaki M, Yoshida K. World Neurosurg. 2019 Nov;131:e176-e185.
  • Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II-III gliomas to establish genetic predictors of poor prognosis. Kuwahara K, Ohba S, Nakae S, Hattori N, Pareira ES, Yamada S, Sasaki H, Abe M, Hasegawa M, Hirose Y. Brain Tumor Pathol. 2019 Oct;36(4):135-143.
  • Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma. Morimoto Y, Tamura R, Ohara K, Kosugi K, Oishi Y, Kuranari Y, Yoshida K, Toda M. J Neurooncol. 2019 Aug;144(1):65-77.
  • Immunological and vascular characteristics in cavernous sinus meningioma. Kosugi K, Tamura R, Ohara K, Morimoto Y, Kuranari Y, Oishi Y, Yoshida K, Toda M. J Clin Neurosci. 2019 Sep;67:198-203.
  • Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors. Sato M, Tamura R, Tamura H, Mase T, Kosugi K, Morimoto Y, Yoshida K, Toda M. J Clin Med. 2019 May 16;8(5):695.
  • Visualization of spatiotemporal dynamics of human glioma stem cell invasion. Tamura R, Miyoshi H, Sampetrean O, Shinozaki M, Morimoto Y, Iwasawa C, Fukaya R, Mine Y, Masuda H, Maruyama T, Narita M, Saya H, Yoshida K, Okano H, Toda M. Mol Brain. 2019 May 6;12(1):45.
  • PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion. Tamura R, Ohara K, Morimoto Y, Kosugi K, Oishi Y, Sato M, Yoshida K, Toda M. Endocr Pathol. 2019 Jun;30(2):81-89.
  • c-Met Expression Is a Useful Marker for Prognosis Prediction in IDH-Mutant Lower-Grade Gliomas and IDH-Wildtype Glioblastomas. Ohba S, Yamada Y, Murayama K, Sandika E, Sasaki H, Yamada S, Abe M, Hasegawa M, Hirose Y. World Neurosurg. 2019 Jun;126:e1042-e1049.
  • A Case of Aggressive Recurrent Intracranial Subdural Hematoma Associated with Angiosarcoma Originating from the Skull. Kanazawa T, Miwa T, Akiyama T, Ohara K, Kosugi K, Nishimoto M, Yoshida K. World Neurosurg. 2019 Jun;126:120-123.
  • Trigeminal Neuralgia Due to Petrosal Bone Deformity. Hirata S, Kobayashi M, Kamamoto D, Kosugi K, Yoshida K, Fujimaki T. World Neurosurg. 2019 Jun;126:79-82.
  • Bridging vein and tentorial sinus in the subtemporal corridor during the anterior transpetrosal approach.
  • Shibao S, Toda M, Fujiwara H, Jinzaki M, Yoshida K. Acta Neurochir (Wien). 2019 Apr;161(4):821-829.
  • A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma. Kikuchi R, Ueda R, Saito K, Shibao S, Nagashima H, Tamura R, Morimoto Y, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. J Clin Med. 2019 Feb 20;8(2):263.
  • Increased Cytotoxicity of Herpes Simplex Virus Thymidine Kinase Expression in Human Induced Pluripotent Stem Cells. Iwasawa C, Tamura R, Sugiura Y, Suzuki S, Kuzumaki N, Narita M, Suematsu M, Nakamura M, Yoshida K, Toda M, Okano H, Miyoshi H. Int J Mol Sci. 2019 Feb 14;20(4):810.
  • Predictive markers for MGMT promoter methylation in glioblastomas. Kanazawa T, Minami Y, Jinzaki M, Toda M, Yoshida K, Sasaki H. Neurosurg Rev. 2019 Dec;42(4):867-876.
  • Endoscopic Endonasal Removal of Large Calcified Pituitary Adenoma: Case Report and Review of the Literature. Murase M, Toda M, Ohara K, Ishihara E, Yoshida K. World Neurosurg. 2019 Mar;123:239-243.
  • Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab. Tamura R, Tanaka T, Ohara K, Miyake K, Morimoto Y, Yamamoto Y, Kanai R, Akasaki Y, Murayama Y, Tamiya T, Yoshida K, Sasaki H. Cancer Sci. 2019 Feb;110(2):499-508.
  • Assessment of Bioabsorbable Hydroxyapatite for Cranial Defect in Children. Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2019 Jan;30(1):e58-e60.
  • Descending musculospinal branch of the ascending pharyngeal artery as a feeder of carotid body tumors: Angio-architecture and embryological consideration. Shibao S, Akiyama T, Ozawa H, Tomita T, Ogawa K, Yoshida K. J Neuroradiol. 2019 May;47(3):187-192.
  • Posterior Distraction First or Fronto-Orbital Advancement First for Severe Syndromic Craniosynostosis. Iida C, Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2019 Jan;30(1):47-49.
  • Interneuronal NMDA receptors regulate long-term depression and motor learning in the cerebellum. Kono M, Kakegawa W, Yoshida K, Yuzaki M. J Physiol. 2019 Feb;597(3):903-920.
  • Endoscopic Endonasal Approach Combined with a Simultaneous Transcranial Approach for Giant Pituitary Tumors. Kuga D, Toda M, Ozawa H, Ogawa K, Yoshida K. World Neurosurg. 2019 Jan;121:173-179.
  • Endonasal Chiasmapexy Using Autologous Cartilage/Bone for Empty Sella Syndrome After Cabergoline Therapy for Prolactinoma. Ishihara E, Toda M, Sasao R, Ozawa H, Saito S, Ogawa K, Yoshida K. World Neurosurg. 2019 Jan;121:145-148.
  • Imaging scoring systems for preoperative molecular diagnoses of lower-grade gliomas. Kanazawa T, Fujiwara H, Takahashi H, Nishiyama Y, Hirose Y, Tanaka S, Yoshida K, Sasaki H. Neurosurg Rev. 2019 Jun;42(2):433-441.

2018年

  • Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma. Kamamoto D, Saga I, Ohara K, Yoshida K, Sasaki H. World Neurosurg. 2018 Dec 26:S1878-8750(18)32890-0.
  • Severe headache in a patient with meningioma showing extensive dural tail correlates with IgG4-positive plasma cells and eosinophils: A case report and review of literature. Kuranari Y, Tamura R, Mikami S, Ohara K, Toda M, Yoshida K. Surg Neurol Int. 2018 Oct 8;9:202.
  • An analysis of the anatomic route of the hypoglossal nerve within the hypoglossal canal using dynamic computed tomography angiography in patients with anterior condylar arteriovenous fistulas. Oishi Y, Akiyama T, Mizutani K, Horiguchi T, Imanishi N, Yoshida K. Clin Neurol Neurosurg. 2018 Nov;174:207-213.
  • Skull Base Venous Anatomy Associated with Endoscopic Skull Base Neurosurgery: A Literature Review. Mizutani K, Akiyama T, Yoshida K, Toda M. World Neurosurg. 2018 Dec;120:405-414.
  • Preoperative Prediction of Solitary Fibrous Tumor/Hemangiopericytoma and Angiomatous Meningioma Using Magnetic Resonance Imaging Texture Analysis. Kanazawa T, Minami Y, Jinzaki M, Toda M, Yoshida K, Sasaki H. World Neurosurg. 2018 Dec;120:e1208-e1216.
  • Treatment Strategy for Tuberculum Sellae Meningiomas Based on a Preoperative Radiological Assessment. Kuga D, Toda M, Yoshida K. World Neurosurg. 2018 Dec;120:e1279-e1288.
  • Pros and cons of using ORBEYE™ for microneurosurgery. Takahashi S, Toda M, Nishimoto M, Ishihara E, Miwa T, Akiyama T, Horiguchi T, Sasaki H, Yoshida K. Clin Neurol Neurosurg. 2018 Nov;174:57-62.
  • Surgical Treatment of Cavernous Sinus Lesion in Patients with Nonfunctioning Pituitary Adenomas via the Endoscopic Endonasal Approach. Toda M, Kosugi K, Ozawa H, Ogawa K, Yoshida K. J Neurol Surg B Skull Base. 2018 Oct;79(Suppl 4):S311-S315.
  • Difference in Immunosuppressive Cells Between Peritumoral Area and Tumor Core in Glioblastoma. Tamura R, Ohara K, Sasaki H, Morimoto Y, Kosugi K, Yoshida K, Toda M. World Neurosurg. 2018 Dec;120:e601-e610.
  • Usefulness of Intraoperative Imaging in a Patient with a Ruptured Aneurysm of the M4 Segment of the Middle Cerebral Artery. Sasao R, Takahashi S, Nishimoto M, Yoshida K. World Neurosurg. 2018 Dec;120:90-95.
  • Dedifferentiated parosteal osteosarcoma of the maxilla: a case report and review of the literature. Miyashita H, Yoshida K, Soma T, Kameyama K, Sasaki A, Hisaoka M, Yazawa M, Morioka H, Takahashi M, Nakagawa T, Kawana H. J Med Case Rep. 2018 Aug 17;12(1):235.
  • Combined Endoscopic Endonasal and Video-microscopic Transcranial Approach with Preoperative Embolization for a Posterior Pituitary Tumor. Yoshida K, Toda M, Akiyama T, Takahashi S, Nishimoto M, Ozawa H, Ikari Y, Yoshida K. World Neurosurg. 2018 Nov;119:201-208.
  • Dual role of macrophage in tumor immunity. Tamura R, Tanaka T, Yamamoto Y, Akasaki Y, Sasaki H. Immunotherapy. 2018 Aug;10(10):899-909.
  • Medulloblastoma in Older Adults: A Case Report and Literature Review. Murase M, Saito K, Abiko T, Yoshida K, Tomita H. World Neurosurg. 2018 Sep;117:25-31.
  • Primary Intracranial Rhabdomyosarcoma in the Cerebellopontine Angle Resected After Preoperative Embolization. Yoshida K, Miwa T, Akiyama T, Nishimoto M, Kamamoto D, Yoshida K. World Neurosurg. 2018 Aug;116:110-115.
  • A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma. Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M. Oncotarget. 2018 Apr 20;9(30):21569-21579.
  • Preoperative Assessment of Pathologic Subtypes of Meningioma and Solitary Fibrous Tumor/Hemangiopericytoma Using Dynamic Computed Tomography: A Clinical Research Study. Arai N, Mizutani K, Takahashi S, Morimoto Y, Akiyama T, Horiguchi T, Mami H, Yoshida K. World Neurosurg. 2018 Jul;115:e676-e680.
  • Association between programmed cell death ligand-1 expression and extracranial metastasis in intracranial solitary fibrous tumor/hemangiopericytoma. Kamamoto D, Ohara K, Kitamura Y, Yoshida K, Kawakami Y, Sasaki H. J Neurooncol. 2018 Sep;139(2):251-259.
  • Surgical Simulation and Custom-Made Implant for Cranial Fibrous Dysplasia. Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2018 Jul;29(5):1352-1353.
  • JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma. Wakabayashi T, Natsume A, Mizusawa J, Katayama H, Fukuda H, Sumi M, Nishikawa R, Narita Y, Muragaki Y, Maruyama T, Ito T, Beppu T, Nakamura H, Kayama T, Sato S, Nagane M, Mishima K, Nakasu Y, Kurisu K, Yamasaki F, Sugiyama K, Onishi T, Iwadate Y, Terasaki M, Kobayashi H, Matsumura A, Ishikawa E, Sasaki H, Mukasa A, Matsuo T, Hirano H, Kumabe T, Shinoura N, Hashimoto N, Aoki T, Asai A, Abe T, Yoshino A, Arakawa Y, Asano K, Yoshimoto K, Shibui S; Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG). J Neurooncol. 2018 Jul;138(3):627-636.
  • Analysis of various tracts of mastoid air cells related to CSF leak after the anterior transpetrosal approach. Tamura R, Tomio R, Mohammad F, Toda M, Yoshida K. J Neurosurg. 2018 Mar 16;130(2):360-367.
  • The Guiding Lateral Z Osteotomy for the Correction of Vertical Orbital Dystopia. Kohno H, Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2018 May;29(3):e325-e327.
  • The analysis of the cerebral venous blood volume in cavernous sinus using 320 row multi-detector CT.
  • Mizutani K, Toda M, Yajima Y, Akiyama T, Fujiwara H, Yoshida K, Jinzaki M. Clin Neurol Neurosurg. 2018 Apr;167:11-16.
  • Intraosseous venous structures adjacent to the jugular tubercle associated with an anterior condylar dural arteriovenous fistula. Mizutani K, Akiyama T, Minami Y, Toda M, Fujiwara H, Jinzaki M, Yoshida K. Neuroradiology. 2018 May;60(5):487-496.
  • Hyperperfusion after Clipping of Aneurysm: A Rare Entity. Nagashima H, Miwa T, Horiguchi T, Tomio R, Nakagawa Y, Yoshida K. J Stroke Cerebrovasc Dis. 2018 May;27(5):1425-1430.
  • Fate of the three embryonic dural sinuses in infants: the primitive tentorial sinus, occipital sinus, and falcine sinus. Mizutani K, Miwa T, Akiyama T, Sakamoto Y, Fujiwara H, Yoshida K. Neuroradiology. 2018 Mar;60(3):325-333.
  • A Giant Osteoma of the Ethmoid Sinus. Ishii T, Sakamoto Y, Miwa T, Yoshida K, Kishi K. J Craniofac Surg. 2018 May;29(3):661-662.
  • Histopathological vascular investigation of the peritumoral brain zone of glioblastomas. Tamura R, Ohara K, Sasaki H, Morimoto Y, Yoshida K, Toda M. J Neurooncol. 2018 Jan;136(2):233-241.
  • Advantages of Staged Angioplasty in a Patient with Internal Carotid Artery Pseudo-Occlusion Besides Prevention of Cerebral Hyperperfusion Syndrome. Takahashi S, Akiyama T, Nakahara J, Yoshizaki T, Suzuki N, Yoshida K. World Neurosurg. 2018 Jan;109:409-412.
  • Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model. Shibao S, Minami N, Koike N, Fukui N, Yoshida K, Saya H, Sampetrean O. Neuro Oncol. 2018 Feb 19;20(3):343-354.
  • Comprehensive genetic characterization of rosette-forming glioneuronal tumors: independent component analysis by tissue microdissection. Kitamura Y, Komori T, Shibuya M, Ohara K, Saito Y, Hayashi S, Sasaki A, Nakagawa E, Tomio R, Kakita A, Nakatsukasa M, Yoshida K, Sasaki H. Brain Pathol. 2018 Jan;28(1):87-93.

2017年

  • Spinal arteriovenous fistula coexisting within a spinal lipoma: report of two cases. Horiuchi Y, Iwanami A, Akiyama T, Hikata T, Watanabe K, Yagi M, Fujita N, Okada E, Nagoshi N, Tsuji O, Ishii K, Yoshida K, Nakamura M, Matsumoto M. Spinal Cord Ser Cases. 2017 Nov 14;3:17079.
  • "Paradoxical" findings of tumor vascularity and oxygenation in recurrent glioblastomas refractory to bevacizumab. Yamamoto Y, Tamura R, Tanaka T, Ohara K, Tokuda Y, Miyake K, Takei J, Akasaki Y, Yoshida K, Murayama Y, Sasaki H. Oncotarget. 2017 Oct 24;8(61):103890-103899.
  • Remote intracranial recurrence of IDH mutant gliomas is associated with TP53 mutations and an 8q gain. Nakae S, Kato T, Murayama K, Sasaki H, Abe M, Kumon M, Kumai T, Yamashiro K, Inamasu J, Hasegawa M, Kurahashi H, Hirose Y. Oncotarget. 2017 Sep 15;8(49):84729-84742.
  • Intraspinosum Middle Meningeal Artery Ligation: A Simple Technique to Control Bleeding in the Middle Fossa During the Anterior Transpetrosal Approach. Shibao S, Borghei-Razavi H, Yoshida K. Oper Neurosurg (Hagerstown). 2017 Apr 1;13(2):163-172.
  • Treatment Recommendations for Adult Patients with Diffuse Gliomas of Grades II and III According to the New WHO Classification in 2016. Sasaki H, Yoshida K. Neurol Med Chir (Tokyo). 2017 Dec 15;57(12):658-666.
  • Unusual Magnetic Resonance Imaging Findings of a Glioblastoma Arising During Treatment with Lenvatinib for Thyroid Cancer. Arai N, Sasaki H, Tamura R, Ohara K, Yoshida K. World Neurosurg. 2017 Nov;107:1047.e9-1047.e15.
  • The Trigeminocardiac Reflex During the Anterior Transpetrosal Approach. Shibao S, Kenawy K, Borghei-Razavi H, Yoshida K. World Neurosurg. 2017 Oct;106:939-944.
  • Postnatal delayed exacerbation of dural sinus malformation associated with brainstem cavernous malformations: A case report. Mizutani K, Miwa T, Akiyama T, Kanazawa T, Nagashima H, Miyakoshi K, Niimi Y, Yoshida K. Interv Neuroradiol. 2017 Oct;23(5):510-515.
  • Diagnosis and treatment for pure aqueductal tumor. Tamura R, Miwa T, Ohira T, Yoshida K. J Clin Neurosci. 2017 Oct;44:260-263.
  • Clinical and Molecular Prognostic Factors for Long-Term Survival of Patients with Glioblastomas in Single-Institutional Consecutive Cohort. Nakagawa Y, Sasaki H, Ohara K, Ezaki T, Toda M, Ohira T, Kawase T, Yoshida K. World Neurosurg. 2017 Oct;106:165-173.
  • Chronic Encapsulated Intracerebral Hematoma: Endoscopic Removal as Minimally Invasive Surgery for a Patient with Alcoholic Cirrhosis. Shibao S, Akiyama T, Yoshida K, Akiyama T. NMC Case Rep J. 2017 Mar 7;4(2):51-53.
  • Crowned Dens Syndrome Occurred in a Patient after Simple Drainage for Chronic Subdural Hematoma: A Case Report. Tamura R, Takahashi S, Kamamoto D, Horikoshi T, Yoshida K. NMC Case Rep J. 2016 Nov 29;4(1):15-17.
  • Functional analysis of the DEPDC1 oncoantigen in malignant glioma and brain tumor initiating cells. Kikuchi R, Sampetrean O, Saya H, Yoshida K, Toda M. J Neurooncol. 2017 Jun;133(2):297-307.
  • Genetic aberrations and molecular biology of skull base chordoma and chondrosarcoma. Kitamura Y, Sasaki H, Yoshida K. Brain Tumor Pathol. 2017 Apr;34(2):78-90.
  • A case of glioblastoma resected immediately after administering bevacizumab: consideration on histopathological findings and safety of surgery. Tokuda Y, Tamura R, Ohara K, Yoshida K, Sasaki H. Brain Tumor Pathol. 2017 Apr;34(2):98-102.
  • Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene. Takenouchi T, Miwa T, Sakamoto Y, Sakaguchi Y, Uehara T, Takahashi T, Kosaki K. Am J Med Genet A. 2017 Jun;173(6):1631-1634.
  • Bevacizumab for malignant gliomas: current indications, mechanisms of action and resistance, and markers of response. Tamura R, Tanaka T, Miyake K, Yoshida K, Sasaki H. Brain Tumor Pathol. 2017 Apr;34(2):62-77.
  • A case of acute subdural hematoma due to bleeding from metastatic chondrosarcoma of the skull. Kosugi K, Takahashi S, Sasaki H, Tamura R, Ohara K, Yoshida K. Surg Neurol Int. 2017 Feb 20;8:23.
  • Is that cranial deformity really due to sleeping position? Kajita H, Sakamoto Y, Takenouchi T, Miwa T, Takahashi T. Pediatr Int. 2017 Apr;59(4):494-496.
  • Analysis of the venous channel within the clivus using multidetector computed tomography digital subtraction venography. Mizutani K, Toda M, Kurasawa J, Akiyama T, Fujiwara H, Jinzaki M, Yoshida K. Neuroradiology. 2017 Mar;59(3):213-219.
  • Delayed and isolated oculomotor nerve palsy following minor head trauma. Nakagawa Y, Toda M, Shibao S, Yoshida K. Surg Neurol Int. 2017 Feb 6;8:20.
  • Leukoencephalopathy, cerebral calcifications, and cysts: A clinical case involving a long-term follow-up and literature review. Tamura R, Ohira T, Emoto K, Fujiwara H, Horikoshi T, Yoshida K. J Neurol Sci. 2017 Feb 15;373:60-65.
  • Long-term Spontaneous Partial Regression of a Cerebral Arteriovenous Malformation: 24-Year Follow-up. Kamamoto D, Takahashi S, Yoshida K. Keio J Med. 2017 Sep 26;66(3):51-53.
  • Functional analysis of KIF20A, a potential immunotherapeutic target for glioma. Saito K, Ohta S, Kawakami Y, Yoshida K, Toda M. J Neurooncol. 2017 Mar;132(1):63-74.
  • Pathological Location of Cranial Nerves in Petroclival Lesions: How to Avoid Their Injury during Anterior Petrosal Approach. Borghei-Razavi H, Tomio R, Fereshtehnejad SM, Shibao S, Schick U, Toda M, Yoshida K, Kawase T. J Neurol Surg B Skull Base. 2016 Feb;77(1):6-13.
  • Molecular-genetic and clinicopathological prognostic factors in patients with gliomas showing total 1p19q loss: gain of chromosome 19p and histological grade III negatively correlate with patient's prognosis. Hayashi S, Kitamura Y, Hirose Y, Yoshida K, Sasaki H. J Neurooncol. 2017 Mar;132(1):119-126.
  • Identification of hemodynamically compromised regions by means of cerebral blood volume mapping utilizing computed tomography perfusion imaging. Takahashi S, Tanizaki Y, Akaji K, Kimura H, Katano T, Suzuki K, Mochizuki Y, Shidoh S, Nakazawa M, Yoshida K, Mihara B. J Clin Neurosci. 2017 Apr;38:74-78.
  • [The Usefulness of Considering Preoperative CT Images for Surgical Clipping in a Patient with a Distal ACA Ruptured Aneurysm]. Takahashi S, Kamamoto D, Ishihara E, Yoshida K. No Shinkei Geka. 2016 Dec;44(12):1065-1068.
  • Influence of backscatter radiation on cranial reconstruction implants. Sakamoto Y, Koike N, Takei H, Ohno M, Miwa T, Yoshida K, Shigematsu N, Kishi K. Br J Radiol. 2017 Feb;90(1070):20150537.
  • Comparison of effectiveness between cork-screw and peg-screw electrodes for transcranial motor evoked potential monitoring using the finite element method. Tomio R, Akiyama T, Ohira T, Yoshida K. Surg Neurol Int. 2016 Nov 11;7(Suppl 32):S791-S796.
  • The Coexistence of Extradural Arteriovenous Fistula and Soft Tissue Arteriovenous Malformation Within the Same Metamere. Arai N, Akiyama T, Yoshida K. World Neurosurg.
  • Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
  • Nakae S, Murayama K, Sasaki H, Kumon M, Nishiyama Y, Ohba S, Adachi K, Nagahisa S, Hayashi T, Inamasu J, Abe M, Hasegawa M, Hirose Y. J Neurooncol. 2017 Jan;131(2):403-412.
  • Transvenous Embolization of the Basilar Plexus Before Endoscopic Transsphenoidal Transclival Surgery. Mizutani K, Akiyama T, Toda M, Kanazawa T, Kamamoto D, Yoshida K. World Neurosurg. 2017 Jan;97:756.e13-756.e18.
  • The impact of several craniotomies on transcranial motor evoked potential monitoring during neurosurgery. Tomio R, Akiyama T, Toda M, Ohira T, Yoshida K. J Neurosurg. 2017 Sep;127(3):543-552.
  • Effects of transcranial stimulating electrode montages over the head for lower-extremity transcranial motor evoked potential monitoring. Tomio R, Akiyama T, Ohira T, Yoshida K. J Neurosurg. 2017 Jun;126(6):1951-1958.

2016年

  • [Pre- and Intra-Operative Supporting Technology for Brain Tumors(1)Endoscopic Endonasal Surgery for Sellar and Clival Lesions]. Toda M. No Shinkei Geka. 2016 Nov;44(11):975-987.
  • Comparative analysis of the anterior transpetrosal approach with the endoscopic endonasal approach to the petroclival region. Muto J, Prevedello DM, Ditzel Filho LF, Tang IP, Oyama K, Kerr EE, Otto BA, Kawase T, Yoshida K, Carrau RL. J Neurosurg. 2016 Nov;125(5):1171-1186.
  • Characteristics of subcortical infarction due to distal MCA penetrating artery occlusion. Suzuki K, Aoki J, Tanizaki Y, Sakamoto Y, Takahashi S, Abe A, Kimura H, Kano T, Suda S, Nishiyama Y, Akaji K, Mihara B, Kimura K. J Neurol Sci. 2016 Sep 15;368:160-4.
  • A case of papillary tumor of the pineal region with a long clinical history: molecular characterization and therapeutic consideration with review of the literature. Kamamoto D, Sasaki H, Ohara K, Mizutani K, Yoshida K. Brain Tumor Pathol. 2016 Oct;33(4):271-275.
  • The outermost "dura-like membrane" of vestibular schwannoma. Tomio R, Yoshida K, Kohno M, Kamamoto D, Mikami S. Surg Neurol Int. 2016 Jun 29;7:71.
  • Improvement of long-term blindness caused by compression from inner-third sphenoid wing meningioma after optic canal decompression: An extremely rare case report. Tamura R, Takahashi S, Horikoshi T, Yoshida K. Surg Neurol Int. 2016 Jun 23;7:67.
  • Usefulness of an Osteotomy Template for Skull Tumorectomy and Simultaneous Skull Reconstruction.
  • Oji T, Sakamoto Y, Miwa T, Nakagawa Y, Yoshida K, Kishi K. J Craniofac Surg. 2016 Sep;27(6):1565-7.
  • Simultaneous decompression of the orbital lateral wall and optic canal for fibrous dysplasia in early adolescence. Tamura R, Miwa T, Sakamoto Y, Kohno M, Kishi K, Yoshida K. Springerplus. 2016 Jun 14;5(1):719.
  • The Analysis of the Petrosal Vein to Prevent Venous Complications During the Anterior Transpetrosal Approach in the Resection of Petroclival Meningioma. Mizutani K, Toda M, Yoshida K. World Neurosurg. 2016 Sep;93:175-82.
  • Analysis of the Medial Opticocarotid Recess in Patients with Pituitary Macroadenoma Using Three-Dimensional Images. Kikuchi R, Toda M, Wakahara S, Fujiwara H, Jinzaki M, Yoshida K. World Neurosurg. 2016 Sep;93:139-43.
  • Histopathological investigation of glioblastomas resected under bevacizumab treatment. Tamura R, Tanaka T, Miyake K, Tabei Y, Ohara K, Sampetrean O, Kono M, Mizutani K, Yamamoto Y, Murayama Y, Tamiya T, Yoshida K, Sasaki H. Oncotarget. 2016 Aug 9;7(32):52423-52435.
  • World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages.
  • Hattori N, Hirose Y, Sasaki H, Nakae S, Hayashi S, Ohba S, Adachi K, Hayashi T, Nishiyama Y, Hasegawa M, Abe M. Cancer Sci. 2016 Aug;107(8):1159-64.
  • A New Technique for Posterior Distraction in Craniosynostosis: The Double-Door Technique. Sakamoto Y, Miwa T, Nakajima H, Yoshida K, Kishi K. J Craniofac Surg. 2016 Jun;27(4):950-2.
  • A ruptured aneurysm in the vasa corona at the craniocervical junction with dysgenesis of the posterior inferior cerebellar artery. Mizutani K, Akiyama T, Kamamoto D, Nagashima H, Yoshida K. BJR Case Rep. 2016 May 8;2(3):20160004.
  • Anterior transpetrosal approach: epidural or subdural? Shibao S, Borghei-Razavi H, Yoshida K. Neurosurg Rev. 2016 Jul;39(3):531-4.
  • The remnant of primary head sinus found in the case of dural arteriovenous fistula: A case report. Mizutani K, Akiyama T, Yoshida K. Interv Neuroradiol. 2016 Aug;22(4):452-6.
  • Fatal hemorrhage in a patient with advanced soft tissue sarcoma following radiation and pazopanib treatment: A case report. Kawasaki K, Hamamoto Y, Fukada J, Adachi M, Sasaki H, Takaishi H, Yoshida K, Kanai T. Oncol Lett. 2016 Apr;11(4):2408-2410.
  • MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53. Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y, Sugihara E, Okano H, Saya H, Kawakami Y, Kawase T, Yoshida K, Toda M. Cancer Res. 2016 May 1;76(9):2813-23
  • [Molecular Classification and Personalized Treatment of Gliomas]. Sasaki H, Yoshida K. No Shinkei Geka. 2016 Mar;44(3):185-201.
  • Sigmoid incision rescue nasoseptal flap technique for endoscopic endonasal skull base surgery. Ozawa H, Tomita T, Watanabe Y, Sekimizu M, Ito F, Ikari Y, Saito S, Toda M, Ogawa K. Acta Otolaryngol. 2016 Jun;136(6):636-40.
  • Giant cell tumors of the clivus: Case report and literature review. Shibao S, Toda M, Yoshida K. Surg Neurol Int. 2015 Nov 25;6(Suppl 25):S623-7.
  • Vascularized middle turbinate flap for the endoscopic endonasal reconstruction of the anterior olfactory groove. Tamura R, Toda M, Kohno M, Watanabe Y, Ozawa H, Tomita T, Ogawa K, Yoshida K. Neurosurg Rev. 2016 Apr;39(2):297-302; discussion 302.
  • Prenatal diagnosis of thrombosed dural sinus malformation with periorbital hemangioma: a case report. Ochiai D, Miyakoshi K, Miwa T, Fukutake M, Kasuga Y, Matsumoto T, Tanaka M. Eur J Obstet Gynecol Reprod Biol. 2016 Mar;198:157-159.
  • Frontotemporal epi- and subdural approach to a cavernous sinus tumor for sphenobasal vein preservation--technical case report. Shibao S, Akiyama T, Tomita H, Kuramae T, Mochizuki Y, Yoshida K. Neurosurg Rev. 2016 Jan;39(1):169-74; discussion 174.
  • Encountering a Basal Vein of Rosenthal Variant During the Anterior Transpetrosal Approach. Shibao S, Fujiwara H, Borghei-Razavi H, Yoshida K. World Neurosurg. 2016 Feb;86:513.e19-22.
  • Analysis of the Intercavernous Sinus in Sellar Lesions Using Multidetector Computed Tomography Digital Subtraction Venography. Mizutani K, Toda M, Yoshida K. World Neurosurg. 2016 Feb;86:336-40.
  • Various patterns of the middle cerebral vein and preservation of venous drainage during the anterior transpetrosal approach. Shibao S, Toda M, Orii M, Fujiwara H, Yoshida K. J Neurosurg. 2016 Feb;124(2):432-9.